Elevance Health, Inc. ELV

396.09 (2.16) (0.54%) as of 25 Sep
Market cap
$86.4B
P/E
17.6×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Elevance Health, Inc. (ELV) P/E ratio

As of 25 September 2026, Elevance Health, Inc. (ELV) trades at a P/E ratio of 17.6×. Over the past ten years it has ranged from 9.5× (March 2020) to 23.4× (July 2021); the current reading is higher than 59% of that period. That is below the Healthcare Plans industry median of 23.8× and below the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 14.0× (3.12%)
FY2024 14.4× (24.28%)
FY2023 19.0× (6.09%)
FY2022 20.3× 8.03%
FY2021 18.8× 4.59%
FY2020 17.9× 9.46%
FY2019 16.4× (11.44%)
FY2018 18.5× 17.52%
FY2017 15.7× 1.19%
FY2016 15.6× 4.06%

Quarterly

Period P/E ratio Change
Jun 2026 17.2× 38.03%
Mar 2026 12.5× (10.77%)
Dec 2025 14.0× 5.64%
Sep 2025 13.2× (20.19%)
42 more quarters

Against its own ten years

Low 9.5× High 23.4×
Ten-year median 16.8×
Current reading's percentile 59

P/E ratio against peers

Company P/E ratio
CLOV Clover Health Investments, Corp. compare n/m
MOH Molina Healthcare, Inc compare n/m
CNC Centene Corporation compare n/m
CI Cigna Group compare 11.3×
OSCR Oscar Health, Inc. compare 17.3×
ELV Elevance Health, Inc. 17.6×
CVS CVS Health Corporation compare 23.3×
UNH UnitedHealth Group Incorporated compare 24.2×
HUM Humana Inc. compare 37.4×
Healthcare Plans industry median 23.8×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on ELV